Skip to main content
Log in

Are Essential Medicines in Malaysia Accessible, Affordable and Available?

  • Research Article
  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Objective:

To assess the pharmaceutical sector to know whether people have access to essential medicines.

Setting:

The study was conducted in 20 public health clinics, five public district drug stores and 20 private retail pharmacies selected randomly in five different areas randomly selected (four states and a federal territory).

Method:

The methodology used was adopted from the World Health Organization study protocol. The degree of attainment of the strategic pharmaceutical objectives of improved access is measured by a list of tested indicators. Access is measured in terms of the availability and affordability of essential medicines, especially to the poor and in the public sector. The first survey in the public health clinics and public district drug stores gathered information about current availability of essential medicines, prevalence of stock-outs and affordability of treatment (except drug stores). The second survey assessed affordability of treatment in public health clinics and private retail pharmacies.

Main Outcome Measure

Availability, stock-out duration, percent of medicines dispensed, accessibility and affordability of key medicines.

Results

The average availability of key medicines in the public health clinics for the country was 95.4%. The average stock-out duration of key medicines was 6.5 days. However, average availability of key medicines in the public district drug stores was 89.2%; with an average stock-out duration of 32.4 days. Medicines prescribed were 100% dispensed to the patients. Average affordability for public health clinics was 1.5 weeks salary and for the private pharmacies, 3.7 weeks salary.

Conclusions:

The present pharmaceutical situation in the context of essential medicines list implementation reflected that the majority of the population in Malaysia had access to affordable essential medicines. If medicines need to be obtained from the private sector, they are hardly affordable. Although the average availability of essential medicines in Malaysia was high being more than 95.0%, in certain areas in Sabah availability was less than 80.0% and still a problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. InstitutionalAuthorNameWHO (2000) The use of essential medicines (Including the Revised Model List of Essential Medicines) Ninth Report of the WHO Expert Committee World Health Organization Geneva

    Google Scholar 

  2. WHO. Twenty-five years of essential medicines progress. Essent Med Monit 2003; 32: 1.

    Google Scholar 

  3. JM Kindermans F Matthys (2001) ArticleTitleIntroductory note: The access to essential medicines campaign Trop Med Int Health 6 IssueID11 955–7 Occurrence Handle10.1046/j.1365-3156.2001.00797.x Occurrence Handle11703852 Occurrence Handle1:STN:280:DC%2BD3MnltFyjtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. S Bennet JD Quick G Velasquez (1997) Public-private roles in the pharmaceutical sector-implications for equitable access and rational medicine use. Health Economic and Medicines Action Programme on Essential Medicines Geneva

    Google Scholar 

  5. Balasubramaniam K. Strategies to ensure availability and affordability of safe and effective medicines of good quality in the Asia Pacific region. International Conference on Medicinal Medicine Policies – The Way Forward. Australian Prescriber, 1995; 20(Suppl  1).

  6. InstitutionalAuthorNameWHO (2001) Core indicators on country pharmaceutical situation World Health Organization Geneva

    Google Scholar 

  7. P Brudon JD Rainhorn MR Reich (1999) Indicators for monitoring national medicine policies EditionNumber2 World Health Organization Geneva

    Google Scholar 

  8. InstitutionalAuthorNameMSH (1995) Rapid pharmaceutical assessment – an indicator-based approach Management Sciences for Health Washington, DC

    Google Scholar 

  9. A Hardon P Brudon-Jakobowiz A Reeler (1992) How to investigate medicine use in communities. Guideline for social research Geneva World Health Organization

    Google Scholar 

  10. InstitutionalAuthorNameMinistry of Health (1996) Antibiotic guidelines 1996 Medical Consensus Development Panel, Ministry of Health Malaysia and Academic of Medicine Malaysia

    Google Scholar 

  11. WHO. WHO Medicines strategic 2002–2003: Framework for action in essential medicines and medicines. http://www.who.int/medicines/strategy/strategy.pdf (3 November, 2002).

  12. B Pecoul P Chirac P Trouiller J Pinel (1999) ArticleTitleAccess to essential medicines in poor countries. A lost battle? JAMA 281 IssueID4 361–7 Occurrence Handle10.1001/jama.281.4.361 Occurrence Handle9929090 Occurrence Handle1:STN:280:DyaK1M7is1Wksg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  13. WHO. Essential medicines and medicines policy: The rational for essential medicines. http://www.who.int/medicines/rationale.shtml (3 November, 2002).

  14. FS Antezana (1992) ArticleTitleEssential medicines: Action for equity World Health 45 IssueID2 7–8

    Google Scholar 

  15. JD Quick (2003) ArticleTitleEssential medicines twenty-five years on: Closing the access gap Health Pol Planning 18 IssueID1 1–3

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed I. M. Ibrahim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saleh, K., Ibrahim, M.I.M. Are Essential Medicines in Malaysia Accessible, Affordable and Available?. Pharm World Sci 27, 442–446 (2005). https://doi.org/10.1007/s11096-005-1318-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-005-1318-8

Keywords

Navigation